Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

The amyloid hypothesis of Alzheimer's disease at 25 years

Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · see citing works

Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204 · see citing works

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · see citing works

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases

Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · see citing works

Alzheimer's disease

Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616 · see citing works

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · see citing works

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065 · see citing works

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works

Clearance systems in the brain—implications for Alzheimer disease

Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678 · see citing works

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease

Da Mesquita, S., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., Contarino, C., Onengut-Gumuscu, S., Farber, E., Raper, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0368-8 · Cited by 1,445 · see citing works

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426 · see citing works

Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · see citing works

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224 · see citing works

Intranasal delivery of biologics to the central nervous system

Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214 · see citing works

Tau-targeting therapies for Alzheimer disease

Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113 · see citing works

Trafficking and Proteolytic Processing of APP

Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075 · see citing works

Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand

Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., & Nordstedt, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8545 · Cited by 963 · see citing works

Current Strategies for Brain Drug Delivery

Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954 · see citing works

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 881 · see citing works

NF-κB in neuronal plasticity and neurodegenerative disorders

Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877 · see citing works

A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease

Baik, S. H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.-I., & Mook-Jung, I. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.005 · Cited by 843 · see citing works

Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery

Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 816 · see citing works

Mitochondria, oxidative stress and neurodegeneration

Federico, A., Cardaioli, E., Pozzo, P. D., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 790 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

Du, H., Guo, L., Yan, S., Sosunov, A. A., McKhann, G. M., & ShiDu Yan, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006586107 · Cited by 704 · see citing works

Randomized trial of verubecestat for mild-to-moderate Alzheimer's disease

Egan, M. F., Kost, J., Tariot, P. N., Aisen, P. S., Cummings, J. L., Vellas, B., Sur, C., Mukai, Y., Voss, T., Furtek, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706441 · Cited by 685 · see citing works

In vivo delivery of miRNAs for cancer therapy: Challenges and strategies

Chen, Y., Gao, D.-Y., & Huang, L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 681 · see citing works

Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease

Kwon, H. J., Cha, M.-Y., Kim, D., Kim, D., Soh, M., Shin, K., Hyeon, T., & Mook‐Jung, I. (2016) · ACS Nano · doi:10.1021/acsnano.5b08045 · Cited by 661 · see citing works

Understanding the functions and relationships of the glymphatic system and meningeal lymphatics

Louveau, A., Plog, B. A., Antila, S., Alitalo, K., Nedergaard, M., & Kipnis, J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90603 · Cited by 640 · see citing works

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Tu, S., Okamoto, S., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 582 · see citing works

Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors

Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00731g · Cited by 576 · see citing works

The road to restoring neural circuits for the treatment of Alzheimer's disease

Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565 · see citing works

Targeting the β secretase BACE1 for Alzheimer’s disease therapy

Yan, R., & Vassar, R. (2014) · Lancet Neurology · doi:10.1016/s1474-4422(13)70276-x · Cited by 550 · see citing works

A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease

Mostafavi, S., Gaiteri, C., Sullivan, S. E., White, C. C., Tasaki, S., Xu, J., Taga, M., Klein, H.-U., Patrick, E., Komashko, V., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0154-9 · Cited by 509 · see citing works

LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease

Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.05.056 · Cited by 503 · see citing works

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis

Tan, C.-C., Yu, J.-T., Wang, H.-F., Tan, M.-S., Meng, X.-F., Wang, C., Jiang, T., Zhu, X.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132690 · Cited by 484 · see citing works

Amyloid toxicity in Alzheimer’s disease

Reiss, A. B., Arain, H. A., Stecker, M. M., Siegart, N. M., & Kasselman, L. J. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0063 · Cited by 447 · see citing works

microRNA dysregulation in neurodegenerative diseases: A systematic review

Juźwik, C. A., Drake, S., Zhang, Y., Paradis-Isler, N., Sylvester, A., Amar‐Zifkin, A., Douglas, C., Morquette, B., Moore, C. S., & Fournier, A. E. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101664 · Cited by 436 · see citing works

Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions

Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429 · see citing works

RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease

Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395 · see citing works

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

Hou, K., Zhao, J., Wang, H., Li, B., Li, K., Shi, X., Wan, K., Ai, J., Lv, J., Wang, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18525-2 · Cited by 373 · see citing works

A phosphate-dependent shift in redox state of cerium oxide nanoparticles and its effects on catalytic properties

Singh, S., Dosani, T., Karakoti, A. S., Kumar, A., Seal, S., & Self, W. T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.073 · Cited by 371 · see citing works

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

Munoz, L., & Ammit, A. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 370 · see citing works

Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?

Braak, H., & Tredici, K. D. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359 · see citing works

Phosphorylated tau interactome in the human Alzheimer's disease brain

Drummond, E., Pires, G., MacMurray, C., Askenazi, M., Nayak, S., Bourdon, M., Safar, J., Ueberheide, B., & Wisniewski, T. (2020) · Brain · doi:10.1093/brain/awaa223 · Cited by 357 · see citing works

Structure-based inhibitors of tau aggregation

Seidler, P. M., Boyer, D. R., Rodríguez, J. A., Sawaya, M. R., Cascio, D., Murray, K. A., Gonen, T., & Eisenberg, D. S. (2017) · Nature Chemistry · doi:10.1038/nchem.2889 · Cited by 340 · see citing works

Novel Therapeutic Approach for the Treatment of Alzheimer's Disease by Peripheral Administration of Agents with an Affinity to β-Amyloid

Matsuoka, Y., Saito, M., LaFrancois, J. J., Saito, M., Gaynor, K., Olm, V., Wang, L., Casey, E., Lu, Y., Shiratori, C., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00029.2003 · Cited by 324 · see citing works

Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity

Liao, Y., Chang, Y., Yoshiike, Y., Chang, Y. C., & Chen, Y. (2012) · Small · doi:10.1002/smll.201201068 · Cited by 324 · see citing works

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Novák, P., Schmidt, R., Kontseková, E., Žilka, N., Kováčech, B., Škrabana, R., Kazmerova, Z., Katina, S., Fialová, Ľ., Prčina, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30331-3 · Cited by 306 · see citing works

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy

Zhou, Y., Zhu, F., Liu, Y., Zheng, M., Wang, Y., Zhang, D., Anraku, Y., Zou, Y., Li, J., Wu, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc7031 · Cited by 304 · see citing works

Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol

Wang, H., Kulas, J. A., Wang, C., Holtzman, D. M., Ferris, H. A., & Hansen, S. B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102191118 · Cited by 294 · see citing works

Sodium rutin ameliorates Alzheimer’s disease–like pathology by enhancing microglial amyloid-β clearance

Pan, R., Ma, J., Kong, X.-X., Wang, X., Li, S., Qi, X., Yan, Y., Cheng, J., Liu, Q., Jin, W., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau6328 · Cited by 290 · see citing works

Tau-Targeted Multifunctional Nanocomposite for Combinational Therapy of Alzheimer’s Disease

Chen, Q., Du, Y., Zhang, K., Liang, Z., Li, J., Yu, H., Ren, R., Feng, J., Jin, Z., Li, F., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07625 · Cited by 280 · see citing works

Lessons from a failed γ-secretase Alzheimer trial

De Strooper, B. (2014) · Cell · doi:10.1016/j.cell.2014.10.016 · Cited by 277 · see citing works

A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

Karran, E. H., & Hardy, J. (2014) · Annals of Neurology · doi:10.1002/ana.24188 · Cited by 275 · see citing works

Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease

Seo, E.-J., Fischer, N., & Efferth, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.030 · Cited by 265 · see citing works

Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer’s disease

Fan, S., Zheng, Y., Liu, X., Fang, W., Chen, X., Liao, W., Jing, X., Lei, M., Tao, E., Ma, Q., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1461955 · Cited by 263 · see citing works

Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255 · see citing works

Nrf2: a dark horse in Alzheimer's disease treatment

Osama, A., Zhang, J., Yao, J., Yao, X., & Fang, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101206 · Cited by 251 · see citing works

Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A

Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., & Terro, F. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.008 · Cited by 250 · see citing works

Derivation and Potential Applications of Human Embryonic Stem Cells

Gepstein, L. (2002) · Circulation Research · doi:10.1161/01.res.0000041435.95082.84 · Cited by 249 · see citing works

Tau immunotherapy for Alzheimer's disease

Pedersen, J. T., & Sigurdsson, E. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.003 · Cited by 247 · see citing works

Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease

Thawkar, B. S., & Kaur, G. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.11.010 · Cited by 247 · see citing works

Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial

Coric, V., Salloway, S., van Dyck, C. H., Dubois, B., Andreasen, N., Brody, M., Curtis, C., Soininen, H., Thein, S., Shiovitz, T., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0607 · Cited by 240 · see citing works

Polyoxometalates as Inhibitors of the Aggregation of Amyloid β Peptides Associated with Alzheimer’s Disease

Geng, J., Li, M., Ren, J., Wang, E., & Qu, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007067 · Cited by 238 · see citing works

Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease

Yin, Z., Raj, D., Saiepour, N., Van Dam, D., Brouwer, N., Holtman, I. R., Eggen, B. J. L., Möller, T., Tamm, J. A., Abdourahman, A., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.021 · Cited by 238 · see citing works

Lipoprotein-Based Nanoparticles Rescue the Memory Loss of Mice with Alzheimer’s Disease by Accelerating the Clearance of Amyloid-Beta

Song, Q., Huang, M., Yao, L., Wang, X., Gu, X., Chen, J., Chen, J., Huang, J., Hu, Q., Kang, T., et al. (2014) · ACS Nano · doi:10.1021/nn4058215 · Cited by 219 · see citing works

Microglial immunophenotype in dementia with Alzheimer’s pathology

CFAS, M., Minett, T., Classey, J., Matthews, F. E., Fahrenhold, M., Taga, M., Brayne, C., Ince, P. G., Nicoll, J. A. R., & Boche, D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0601-z · Cited by 219 · see citing works

Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Diseases with Compromise to the Blood Brain Barrier

Krol, S., Macrez, R., Docagne, F., Defer, G. L., Laurent, S., Rahman, M., Hajipour, M. J., Kehoe, P. G., & Mahmoudi, M. (2012) · Chemical Reviews · doi:10.1021/cr200472g · Cited by 217 · see citing works

Resveratrol attenuates oxidative damage through activating mitophagy in an in vitro model of Alzheimer’s disease

Wang, H., Jiang, T., Li, W., Gao, N., & Zhang, T. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.10.021 · Cited by 214 · see citing works

Nanotechnology-based strategies for siRNA brain delivery for disease therapy

Zheng, M., Tao, W., Zou, Y., Farokhzad, O. C., & Shi, B. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.01.006 · Cited by 210 · see citing works

Self healing hydrogels composed of amyloid nano fibrils for cell culture and stem cell differentiation

Jacob, R. S., Ghosh, D., Singh, P. K., Basu, S. K., Jha, N. N., Das, S., Sukul, P. K., Patil, S. P., Sathaye, S., Kumar, A., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.002 · Cited by 203 · see citing works

Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives

Wang, Y., Zhou, H., & Zhou, X. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.004 · Cited by 202 · see citing works

Mechanisms of Cell Signaling and Inflammation in Alzheimers Disease

Ho, G. J., Drego, R., Hakimian, E., & Masliah, E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010053586237 · Cited by 199 · see citing works

Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease

Henley, D., Raghavan, N., Sperling, R., Aisen, P., Raman, R., & Romano, G. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1813435 · Cited by 197 · see citing works

A Self-Destructive Nanosweeper That Captures and Clears Amyloid β-Peptides

Luo, Q., Lin, Y.-X., Yang, P.-P., Wang, Y., Qi, G.-B., Qiao, Z.-Y., Li, B.-N., Zhang, K., Zhang, J.-P., Wang, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04255-z · Cited by 191 · see citing works

Self-Protecting Biomimetic Nanozyme for Selective and Synergistic Clearance of Peripheral Amyloid-β in an Alzheimer’s Disease Model

Ma, M., Liu, Z., Gao, N., Pi, Z., Du, X., Ren, J., & Qu, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c08395 · Cited by 191 · see citing works

Therapeutic strategies for Alzheimer's disease

Wolfe, M. S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd938 · Cited by 189 · see citing works

Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities

Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00597-3 · Cited by 189 · see citing works

Custom‐Made Ceria Nanoparticles Show a Neuroprotective Effect by Modulating Phenotypic Polarization of the Microglia

Zeng, F., Wu, Y., Li, X., Ge, X., Guo, Q., Lou, X., Cao, Z., Hu, B., Long, N. J., Mao, Y., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802309 · Cited by 186 · see citing works

Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity

Stefani, M. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07889.x · Cited by 183 · see citing works

Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases

Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181 · see citing works

A fluid connection: Cholesterol and Aβ

Wolozin, B. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101123198 · Cited by 179 · see citing works

Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes

Rogers, J., Li, R., Mastroeni, D., Grover, A., Leonard, B., Ahern, G., Cao, P., Kolody, H., Vedders, L., Kolb, W. P., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.043 · Cited by 175 · see citing works

Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

Nalivaeva, N. N., & Turner, A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14593 · Cited by 172 · see citing works

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease

Sonawane, S. K., Ahmad, A., & Chinnathambi, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b01411 · Cited by 166 · see citing works

Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures

Lue, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00311-6 · Cited by 165 · see citing works

Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer’s Disease Mice

Zhao, Y., Cai, J., Liu, Z., Li, Y., Zheng, C., Zheng, Y., Chen, Q., Chen, H., Ma, F., An, Y., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03644 · Cited by 163 · see citing works

Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease

Wang, P., Zheng, X., Guo, Q., Yang, P., Pang, X., Qian, K., Lü, W., Zhang, Q., & Jiang, X. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.034 · Cited by 162 · see citing works

Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia

Lü, Y., Guo, Z., Zhang, Y., Li, C., Zhang, Y., Guo, Q., Chen, Q., Chen, X., He, X., Liu, L., et al. (2018) · Advanced Science · doi:10.1002/advs.201801586 · Cited by 162 · see citing works

Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1–42-induced oxidative stress

Amin, F. U., Shah, S. A., Badshah, H., Khan, M., & Kim, M. O. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0227-4 · Cited by 161 · see citing works

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer’s Disease

Mondragón‐Rodríguez, S., Perry, G. L., Zhu, X., Moreira, P. I., Acevedo, M., & Williams, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/940603 · Cited by 156 · see citing works

Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis

Castellano, J. M., Deane, R., Gottesdiener, A. J., Verghese, P. B., Stewart, F. R., West, T., Paoletti, A. C., Kasper, T. R., DeMattos, R. B., Zlokovic, B. V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206446109 · Cited by 154 · see citing works

Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles

Huang, F., Wang, J., Qu, A., Shen, L., Liu, J., Liu, J., Zhang, Z., An, Y., & Shi, L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400735 · Cited by 152 · see citing works

Curcumin-conjugated Nanoliposomes with High Affinity for Aβ Deposits: Possible Applications to Alzheimer Disease

Lazar, A. N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S. G., & Duyckaerts, C. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.11.004 · Cited by 149 · see citing works

β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects*♦

Hitt, B. D., Riordan, S., Kukreja, L., Eimer, W. A., Rajapaksha, T. W., & Vassar, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415505 · Cited by 148 · see citing works

Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model

Carradori, D., Balducci, C., Re, F., Brambilla, D., Droumaguet, B. L., Flores, O., Gaudin, A., Mura, S., Forloni, G., Ordóñez‐Gutiérrez, L., et al. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.12.006 · Cited by 141 · see citing works

Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents

Du, Z., Li, M. C., Ren, J., & Qu, X. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00055 · Cited by 139 · see citing works

Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

Liu, P., Zhang, T., Chen, Q., Li, C., Chu, Y., Guo, Q., Zhang, Y., Zhou, W., Chen, H., Zhou, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100746 · Cited by 137 · see citing works

Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease

Sun, J., Wei, C., Liu, Y., Xie, W., Xu, M., Zhou, H., & Liu, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.027 · Cited by 133 · see citing works

Endo/Lysosome‐Escapable Delivery Depot for Improving BBB Transcytosis and Neuron Targeted Therapy of Alzheimer's Disease

Cai, L., Yang, C., Jia, W., Liu, Y., Xie, R., Lei, T., Yang, Z., He, X., Tong, R., & Gao, H. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909999 · Cited by 132 · see citing works

A Nanoformulation‐Mediated Multifunctional Stem Cell Therapy with Improved Beta‐Amyloid Clearance and Neural Regeneration for Alzheimer's Disease

Huang, D., Cao, Y., Yang, X., Liu, Y., Zhang, Y., Li, C., Chen, G., & Wang, Q. (2021) · Advanced Materials · doi:10.1002/adma.202006357 · Cited by 131 · see citing works

GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer’s Disease

Huang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127 · see citing works

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology

Koelsch, G. (2017) · Molecules · doi:10.3390/molecules22101723 · Cited by 125 · see citing works

Mesoporous Silica Nanoparticle‐based H2O2 Responsive Controlled‐Release System Used for Alzheimer's Disease Treatment

Geng, J., Li, M., Wu, L., Chen, C., & Qu, X. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200067 · Cited by 124 · see citing works

Untitled work

(2012) · doi:10.1038/nrneurol.2012.118 · Cited by 122 · see citing works

Magnetite/Ceria Nanoparticle Assemblies for Extracorporeal Cleansing of Amyloid‐β in Alzheimer's Disease

Kim, D., Kwon, H. J., & Hyeon, T. (2019) · Advanced Materials · doi:10.1002/adma.201807965 · Cited by 122 · see citing works

LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases

Guo, Q., Zhu, Q., Miao, T., Tao, J., Ju, X., Sun, Z., Li, H., Xu, G., Chen, H., & Han, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.031 · Cited by 119 · see citing works

Polyoxometalate-based nanozyme: Design of a multifunctional enzyme for multi-faceted treatment of Alzheimer’s disease

Gao, N., Dong, K., Zhao, A., Sun, H., Wang, Y., Ren, J., & Qu, X. (2016) · Nano Research · doi:10.1007/s12274-016-1000-6 · Cited by 118 · see citing works

Treatments for Alzheimer's disease emerge

Selkoe, D. J. (2021) · Science · doi:10.1126/science.abi6401 · Cited by 117 · see citing works

Traceable Nanoparticle Delivery of Small Interfering RNA and Retinoic Acid with Temporally Release Ability to Control Neural Stem Cell Differentiation for Alzheimer's Disease Therapy

Zhang, R., Li, Y., Hu, B., Lu, Z., Zhang, J., & Zhang, X. (2016) · Advanced Materials · doi:10.1002/adma.201600554 · Cited by 116 · see citing works

Cell‐Traction‐Triggered On‐Demand Electrical Stimulation for Neuron‐Like Differentiation

Liu, Z., Cai, M., Zhang, X., Yu, X., Wang, S., Wan, X., Wang, Z. L., & Li, L. (2021) · Advanced Materials · doi:10.1002/adma.202106317 · Cited by 116 · see citing works

Tau as a therapeutic target in neurodegenerative disease

Himmelstein, D. S., Ward, S., Lancia, J. K., Patterson, K. R., & Binder, L. I. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.001 · Cited by 113 · see citing works

Self‐Assembled Peptide–Polyoxometalate Hybrid Nanospheres: Two in One Enhances Targeted Inhibition of Amyloid β‐Peptide Aggregation Associated with Alzheimer's Disease

Li, M. C., Xu, C., Wu, L. J., Ren, J., Wang, E., & Qu, X. (2013) · Small · doi:10.1002/smll.201202612 · Cited by 111 · see citing works

Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice

Iwata, N., Sekiguchi, M., Hattori, Y., Takahashi, A., Asai, M., Ji, B., Higuchi, M., Staufenbiel, M., Muramatsu, S., & Saido, T. C. (2013) · Scientific Reports · doi:10.1038/srep01472 · Cited by 107 · see citing works

Brain‐Penetration and Neuron‐Targeting DNA Nanoflowers Co‐Delivering miR‐124 and Rutin for Synergistic Therapy of Alzheimer's Disease

Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022) · Small · doi:10.1002/smll.202107534 · Cited by 103 · see citing works

Dynamic Electromechanical Hydrogel Matrices for Stem Cell Culture

Lim, H. L., Chuang, J. C., Tran, T. A., Aung, A., Arya, G., & Varghese, S. (2010) · Advanced Functional Materials · doi:10.1002/adfm.201001519 · Cited by 102 · see citing works

Copper prevents amyloid-β1–42 from forming amyloid fibrils under near-physiological conditions in vitro

Mold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C. (2013) · Scientific Reports · doi:10.1038/srep01256 · Cited by 101 · see citing works

Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease

Shen, Y., Hua, L., Yeh, C., Shen, L., Ying, M., Zhang, Z., Liu, G., Li, S., Chen, S., Chen, X., et al. (2020) · Theranostics · doi:10.7150/thno.44152 · Cited by 95 · see citing works

Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review

Yuksel, M., & Tacal, Ö. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172415 · Cited by 94 · see citing works

Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating

Mullard, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00217-7 · Cited by 94 · see citing works

Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance

Yao, L., Gu, X. Q., Song, Q., Wang, X., Huang, M., Meng, H., Hou, L., Kang, T., Chen, J., Chen, H., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.055 · Cited by 91 · see citing works

Recombinant pre-miR-29b for Alzheimer´s disease therapeutics

Pereira, P., Tomás, J., Queiroz, J., Figueiras, A., & Sousa, F. (2016) · Scientific Reports · doi:10.1038/srep19946 · Cited by 90 · see citing works

Peptide‐modified, hyaluronic acid‐based hydrogels as a 3D culture platform for neural stem/progenitor cell engineering

Seidlits, S. K., Liang, J., Bierman, R. D., Sohrabi, A., Karam, J., Holley, S. M., Cepeda, C., & Walthers, C. M. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36603 · Cited by 87 · see citing works

Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice

Ordóñez‐Gutiérrez, L., Re, F., Bereczki, E., Ioja, E., Gregori, M., Andersen, A. J., Antón, M., Moghimi, S. M., Pei, J.-J., Masserini, M., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.09.015 · Cited by 86 · see citing works

BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology

Peters, F., Salihoglu, H., Rodrigues, E. F., Herzog, É., Blume, T., Filser, S., Dorostkar, M. M., Shimshek, D. R., Brose, N., Neumann, U., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1804-9 · Cited by 86 · see citing works

Stem cell therapy for Alzheimer’s disease and related disorders: current status and future perspectives

Tong, L. M., Fong, H., & Huang, Y. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.124 · Cited by 83 · see citing works

Gold Nanocage‐Based Dual Responsive “Caged Metal Chelator” Release System: Noninvasive Remote Control with Near Infrared for Potential Treatment of Alzheimer's Disease

Shi, P., Li, M., Ren, J., & Qu, X. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201301015 · Cited by 82 · see citing works

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction

Liu, R., Yang, J., Liu, L., Lü, Z., Shi, Z., Ji, W., Shen, J., & Zhang, X. (2019) · Advanced Science · doi:10.1002/advs.201901555 · Cited by 79 · see citing works

A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease

Yang, H. N., Mu, W., Wei, D., Zhang, Y., Duan, Y., Gao, J., Gong, X., Wang, H., Wu, X., Tao, H., et al. (2020) · Advanced Science · doi:10.1002/advs.201902906 · Cited by 78 · see citing works

Recent advances in the design and applications of amyloid-β peptide aggregation inhibitors for Alzheimer’s disease therapy

Jokar, S., Khazaei, S., Behnammanesh, H., Shamloo, A., Erfani, M., Beiki, D., & Bavi, O. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00606-2 · Cited by 76 · see citing works

Preclinical validation of a potent γ-secretase modulator for Alzheimer’s disease prevention

Rynearson, K. D., Ponnusamy, M., Prikhodko, O., Xie, Y., Zhang, C., Nguyen, P., Hug, B., Sawa, M., Becker, A., Spencer, B., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202560 · Cited by 76 · see citing works

Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer's disease

Ji, D., Wu, X., Li, D., Liu, P., Zhang, S., Gao, D., Gao, F., Zhang, M., & Xiao, Y. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.079 · Cited by 75 · see citing works

Carbon nitride-based nanocaptor: An intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease

Gong, L., Zhang, X., Ge, K., Yin, Y., Machuki, J. O., Yang, Y. Q., Shi, H., Geng, D., & Gao, F. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120483 · Cited by 72 · see citing works

A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies

Imbimbo, B. P., Ippati, S., Watling, M., & Balducci, C. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12453 · Cited by 72 · see citing works

Engineering the human pluripotent stem cell microenvironment to direct cell fate

Hazeltine, L. B., Selekman, J. A., & Palecek, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.002 · Cited by 68 · see citing works

A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer’s disease mice

Zheng, X., Pang, X., Yang, P., Xu, W., Wei, Y., Guo, Q., Zhang, Q., & Jiang, X. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.029 · Cited by 68 · see citing works

Reassembly of native components with donepezil to execute dual-missions in Alzheimer's disease therapy

Zhang, H., Zhao, Y., Yu, M., Zhao, Z., Liu, P., Cheng, H., Ji, Y., Jin, Y., Sun, B., Zhou, J., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.008 · Cited by 67 · see citing works

Self-triggered click reaction in an Alzheimer's disease model: in situ bifunctional drug synthesis catalyzed by neurotoxic copper accumulated in amyloid-β plaques

Du, Z., Yu, D., Du, X., Scott, P., Ren, J., & Qu, X. (2019) · Chemical Science · doi:10.1039/c9sc04387j · Cited by 67 · see citing works

Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and β-Amyloid Aggregation

Xu, M., Zhou, H., Liu, Y., Sun, J., Xie, W., Zhao, P., & Liu, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08230 · Cited by 65 · see citing works

Conformation‐dependent single‐chain variable fragment antibodies specifically recognize beta‐amyloid oligomers

Wang, X.-P., Zhang, J.-H., Wang, Y.-J., Feng, Y. N., Zhang, X., Sun, X.-X., Li, J.-L., Du, X.-T., Lambert, M. P., Yang, S.-G., et al. (2009) · FEBS Letters · doi:10.1016/j.febslet.2008.12.064 · Cited by 61 · see citing works

Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease

Zhu, L., Xu, L., Wu, X., Dèng, F., Ma, R., Liu, Y., Huang, F., & Shi, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00257 · Cited by 59 · see citing works

Mapping the multicausality of Alzheimer’s disease through group model building

Uleman, J. F., Melis, R. J. F., Quax, R., van der Zee, E. A., Thijssen, D. H. J., Dresler, M., van de Rest, O., van der Velpen, I. F., Adams, H. H. H., Schmand, B. A., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00228-7 · Cited by 56 · see citing works

γ-Secretase and its modulators: Twenty years and beyond

Xia, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.011 · Cited by 54 · see citing works

Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice

de Retana, S. F., Marazuela, P., Solé, M., Colell, G., Bonaterra‐Pastra, A., Sánchez‐Quesada, J. L., Montaner, J., Maspoch, D., Cano‐Sarabia, M., & Hernández‐Guillamón, M. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0498-8 · Cited by 53 · see citing works

A Conditionally Releasable “Do not Eat Me” CD47 Signal Facilitates Microglia‐Targeted Drug Delivery for the Treatment of Alzheimer's Disease

Zhang, L., Liu, X., Liu, D., Yu, X., Zhang, L. L., Zhu, J., Lü, S., & Liu, R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910691 · Cited by 53 · see citing works

Study of a Bifunctional Aβ Aggregation Inhibitor with the Abilities of Antiamyloid-β and Copper Chelation

Zhang, Q., Hu, X., Wang, W., & Yuan, Z. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01603 · Cited by 50 · see citing works

miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion

Zhang, X., Huang, X.-W.-Y., Chen, F., Li, Q., Cui, J., Sun, J., & Li, L. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9845-y · Cited by 49 · see citing works

Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis

de Retana, S. F., Cano‐Sarabia, M., Marazuela, P., Sánchez‐Quesada, J. L., García‐León, A., Montañola, A., Montaner, J., Maspoch, D., & Hernández‐Guillamón, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-15215-w · Cited by 47 · see citing works

Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia

Versijpt, J. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132639 · Cited by 46 · see citing works

β-amyloid: The known unknowns

Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45 · see citing works

Electrically pulsatile responsive drug delivery platform for treatment of Alzheimer’s disease

Wu, L. J., Wang, J., Gao, N., Ren, J., Zhao, A., & Qu, X. (2015) · Nano Research · doi:10.1007/s12274-015-0750-x · Cited by 43 · see citing works

Effective suppression of the modified PHF6 peptide/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive/therapeutic “functional food”

Bijari, N., Balalaie, S., Akbari, V., Golmohammadi, F., Moradi, S., Adibi, H., & Khodarahmi‬, R. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.08.175 · Cited by 43 · see citing works

Se/Ru nanoparticles as inhibitors of metal-induced Aβ aggregation in Alzheimer's disease

Yang, L., Chen, Q., Liu, Y. M., Zhang, J., Sun, D., Zhou, Y., & Liu, J. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21586e · Cited by 41 · see citing works

Survival, proliferation and differentiation enhancement of neural stem cells cultured in three-dimensional polyethylene glycol-RGD hydrogel with tenascin

Naghdi, P., Tiraihi, T., Ganji, F., Darabi, S., Taheri, T., & Kazemi, H. (2014) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1958 · Cited by 39 · see citing works

Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid

Eufemi, M., Cocchiola, R., Romaniello, D., Correani, V., Di Francesco, L., Fabrizi, C., Maras, B., & Schininà, M. E. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.01.007 · Cited by 39 · see citing works

High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics

Jin, Y., Chifodya, K., Han, G., Jiang, W., Chen, Y., Shi, Y., Xu, Q., Xi, Y., Wang, J., Zhou, J., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.018 · Cited by 39 · see citing works

Reactivity of Diphenylpropynone Derivatives Toward Metal-Associated Amyloid-β Species

Pithadia, A. S., Kochi, A., Soper, M. T., Beck, M. W., Liu, Y., Lee, S., DeToma, A. S., Ruotolo, B. T., & Lim, M. H. (2012) · Inorganic Chemistry · doi:10.1021/ic302084g · Cited by 38 · see citing works

A Near‐Infrared Responsive Drug Sequential Release System for Better Eradicating Amyloid Aggregates

Ma, M., Gao, N., Sun, Y., Ren, J., & Qu, X. (2017) · Small · doi:10.1002/smll.201701817 · Cited by 38 · see citing works

Deep Red Blinking Fluorophore for Nanoscopic Imaging and Inhibition of β-Amyloid Peptide Fibrillation

Ma, Y., Ye, Z., Zhang, C., Wang, X., Li, H., Wong, M. S., Luo, H., & Xiao, L. (2020) · ACS Nano · doi:10.1021/acsnano.0c03400 · Cited by 38 · see citing works

Natural Phyto-Antioxidant Albumin Nanoagents to Treat Advanced Alzheimer’s Disease

Dou, Y., Zhao, D., Yang, F., Tang, Y., & Chang, J. K. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07281 · Cited by 38 · see citing works

Release of methylene blue from graphene oxide-coated electrospun nanofibrous scaffolds to modulate functions of neural progenitor cells

Wang, L., Liu, X., Fu, J., Ning, X., Zhang, M., Jiang, Z., Cheng, G., Zhu, Y., & Zhang, Z. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.036 · Cited by 35 · see citing works

Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome

Salwa, & Kumar, L. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.007 · Cited by 32 · see citing works

Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine Polyplexes

Pereira, P., Barreira, M., Cruz, C., Tomás, J., Luís, Â., Pedro, A. Q., Queiroz, J. A., & de Sousa, F. P. (2020) · Pharmaceuticals · doi:10.3390/ph13100314 · Cited by 30 · see citing works

Rational design of a “sense and treat” system to target amyloid aggregates related to Alzheimer’s disease

Du, Z., Gao, N., Guan, Y., Ding, C., Sun, Y., Ren, J., & Qu, X. (2017) · Nano Research · doi:10.1007/s12274-017-1815-9 · Cited by 29 · see citing works

Near-infrared target enhanced peripheral clearance of amyloid-β in Alzheimer's disease model

Ma, M., Liu, Z., Gao, N., Dong, K., Pi, Z., Kang, L., Du, X., Ren, J., & Qu, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121065 · Cited by 29 · see citing works

Comparative analysis of protective effects of curcumin, curcumin-β-cyclodextrin nanoparticle and nanoliposomal curcumin on unsymmetrical dimethyl hydrazine poisoning in mice

Li, W., Zhou, M., Xu, N., Hu, Y. X., Wang, C., Li, D., Liu, L., & Li, D. (2016) · Bioengineered · doi:10.1080/21655979.2016.1197029 · Cited by 27 · see citing works

Design and Engineering of Amyloid Aggregation‐Prone Fragments and Their Antimicrobial Conjugates with Multi‐Target Functionality

Zhang, Y., Tang, Y., Liu, Y., Zhang, D., & Zheng, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202102978 · Cited by 25 · see citing works

PKCε Promotes HuD-Mediated Neprilysin mRNA Stability and Enhances Neprilysin-Induced Aβ Degradation in Brain Neurons

Lim, C. S., & Alkon, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097756 · Cited by 24 · see citing works

Structural and mechanistic insights into the inhibition of amyloid-β aggregation by Aβ39-42 fragment derived synthetic peptides

Kapadia, A., Sharma, K. K., Maurya, I. K., Singh, V., Khullar, M., & Jain, R. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113126 · Cited by 18 · see citing works

The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of β‐amyloid aggregation

Samani, E. K., Mofid, M. R., & Malakoutikhah, M. (2019) · Journal of Peptide Science · doi:10.1002/psc.3227 · Cited by 15 · see citing works

Methionine oxidation: Implications for the mechanism of toxicity of the β-amyloid peptide from Alzheimer's disease

Ciccotosto, G. D., Barnham, K. J., Cherny, R. A., Masters, C. L., Bush, A. I., Curtain, C. C., Cappai, R., & Tew, D. J. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442572 · Cited by 15 · see citing works

Hydrogels Derivatized With Cationic Moieties or Functional Peptides as Efficient Supports for Neural Stem Cells

Glotzbach, K., Stamm, N., Weberskirch, R., & Faissner, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00475 · Cited by 13 · see citing works

Legumain-induced intracerebrally crosslinked vesicles for suppressing efflux transport of Alzheimer's disease multi-drug nanosystem

Jiang, F., Ren, J., Gao, Y., Wang, J., Zhao, Y., & Dai, F. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.024 · Cited by 11 · see citing works

Methionine oxidation: Implications for the mechanism of toxicity of the β-amyloid peptide from Alzheimer's disease

Ciccotosto, G. D., Barnham, K. J., Cherny, R. A., et al. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-004-2394-7 · Cited by 6 · see citing works

The Aggregation of Aβ42 Induced by Nano Copper and the Antagonistic Action of Polysaccharides

Wang, W., Zhang, G., & Zou, J. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1385-1 · Cited by 4 · see citing works

Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer’s Disease

Jiang, S., Cai, G., Yang, Z., Shi, H., Zeng, H., Ye, Q., Hu, Z., & Wang, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c13150 · Cited by 133 · see citing works

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease

Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56 · see citing works

Current Anti-Amyloid-β Therapy for Alzheimer’s Disease Treatment: From Clinical Research to Nanomedicine

Zhao, Z., Liu, Y., Ruan, S., & Hu, Y. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s444115 · Cited by 49 · see citing works

Biomarker‐Responsive Nanosystems for Chronic Disease Theranostics

Fu, Q., Yu, L., Wang, Y., Li, P., & Song, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202206300 · Cited by 43 · see citing works

Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer’s Diseases

Yang, H., Tan, H., Wen, H., Xin, P., Liu, Y., Deng, Z., Xu, Y., Gao, F., Zhang, L., Ye, Z., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c11966 · Cited by 37 · see citing works

Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery

Wu, Y., Rakotoarisoa, M., Angelov, B., Deng, Y., & Angelova, A. (2022) · Nanomaterials · doi:10.3390/nano12132267 · Cited by 21 · see citing works

Nasal delivery of polymeric nanoDisc mobilizes a synergy of central and peripheral amyloid-β clearance to treat Alzheimer’s disease

Zhang, H., Chen, Y., Yu, M., Xi, Y., Han, G., Jin, Y., Wang, G.-J., Sun, X., Zhou, J., & Ding, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304213120 · Cited by 21 · see citing works

ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson’s disease therapy

Fan, Z., Jin, H., Tan, X., Li, Y., Shi, D., Wang, Q., Meng, J., Li, W., Chen, C., Peng, L., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143245 · Cited by 19 · see citing works

Engineered nanoparticles for the treatment of Alzheimer’s disease

Jia, J., Zhao, S., Zhao, J., & Gao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510798 · Cited by 17 · see citing works

Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives

Zakharova, L. Y., Gaynanova, G. A., Vasilieva, E. A., Vasileva, L. A., Pavlov, R. V., Kashapov, R. R., Petrov, K. A., & Sinyashin, O. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221115103513 · Cited by 16 · see citing works

Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer’s disease

Zhang, X., Hu, H., Li, Q., Zhao, Y., Zhang, Z., Zhao, S., Xu, L., Ma, R., Huang, F., & Shi, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102168 · Cited by 14 · see citing works

Biofilm-modified Prussian blue improves memory function in late-stage Alzheimer’s disease mice with triple therapy

Li, L., Zhang, J., Zhang, Y., Zhao, R., Yang, F., Yan, Y., Wang, Q., & Xie, M. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125112 · Cited by 13 · see citing works

A superior near infrared fluorescent probe for revealing the relationship between peroxynitrite and Alzheimer's disease

Zhou, Z., Fang, C., Shen, Y., Zhang, X., Li, H., & Zhang, Y. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135971 · Cited by 12 · see citing works

Potential therapeutic targets for Alzheimer’s disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy

Li, Y., Yang, C., Liu, X., Shu, J., Zhao, N., Sun, Z., Tabish, M. S., Hong, Y., Liu, E., Wei, N., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.009 · Cited by 10 · see citing works

Facile synthesis of EGCG modified Au nanoparticles and their inhibitory effects on amyloid protein aggregation

Wu, T., Zhang, Y., Li, H., Pan, Z., Ding, J., Zhang, W., Cai, S., & Yang, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136501 · Cited by 9 · see citing works

Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer’s disease

Hao, M., Chu, J., Zhang, T., Yin, T., Gu, Y., Liang, W., Ji, W., Zhuang, J., Liu, Y., Gao, J., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01736 · Cited by 8 · see citing works

Self-Assembled Poly(rosmarinic acid) Nanoantioxidant for Enhanced Acute Liver Injury Treatment

Tang, P., Wu, H., Wang, M., Zhang, R., Liang, B., Li, X., & Xiao, W. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c02555 · Cited by 8 · see citing works

Research trends of piezoelectric materials in neurodegenerative disease applications

Wang, X., Sun, Y., Han, C., Meng, X., Wen, K., Wu, J., Min, P., Li, K., & Zhang, Y. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.022 · Cited by 7 · see citing works

Prussian blue nanocages as efficient radical scavengers and photothermal agents for reducing amyloid-beta induced neurotoxicity

Wu, T., Zhang, X., Cai, S., Zhang, W., & Yang, R. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114369 · Cited by 6 · see citing works

Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer’s disease

Chen, J., Zhang, X., Sun, J., Zhi, Y., Xie, Z., Guan, Y., Zhang, Z., & Wu, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03709-z · Cited by 5 · see citing works

The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease

Tang, L., Liu, F., Sun, X., Yang, J., Liu, Y., Pan, X., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04160-7 · Cited by 5 · see citing works

Pharmacokinetics and pharmacodynamics of various novel formulations targeting Alzheimer's disease

Gawade, A. R., Polshettiwar, S. A., Hingalajia, H., Prajapati, B. G., & Singh, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00027-3 · Cited by 3 · see citing works

Nanomaterials for Alzheimer’s disease: emerging strategies in diagnosis and therapy

Na, Y., Bai, J., Zhang, N., Geng, F., & Wang, X.-J. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04281-w · Cited by 2 · see citing works

Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders

Yadav, V. K., Tahira, S., Jyothi, R., Kumar, P., Karthikeyan, J., Choudhary, N., Verma, R. K., Patel, A., & Zairov, R. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273384176250929130818 · Cited by 1 · see citing works

Diagnosis of Amnesic Mild Cognitive Impairment Using MGS-WBC and VGBN-LM Algorithms

Cai, C., Cao, J., Yang, C., & Chen, E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.893250 · Cited by 1 · see citing works

Research Progress of Stem Cell Exosomes in Alzheimer’s Disease

古, 良. (2023) · Bioprocess · doi:10.12677/bp.2023.132013

Peptide functionalization of a brain-targeting hybrid nanocarrier for enhanced drug transport in Alzheimer's disease

Dong, Y.-Y., Wang, J.-L., Peng, S., Liao, X., Qi, L., Huang, Q.-Y., & Liu, H. (2026) · New Journal of Chemistry · doi:10.1039/d6nj01716a

Nanomedicine in the treatment of Alzheimer’s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology

Dong, N., Ali‐Khiavi, P., Ghavamikia, N., Pakmehr, S., Sotoudegan, F., Hjazi, A. M., Gargari, M. K., Gargari, H. K., Behnamrad, P., Rajabi, M., et al. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07871-4 · Cited by 19 · see citing works

Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease

Li, J., Guo, L., Cai, W., Mei, J., Liu, J., & Liu, Y. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2645830 · Cited by 14 · see citing works

Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and Clinical Trials: Challenges, Promises and Limitations

Bukhari, S. N. A. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210910162750 · Cited by 16 · see citing works

The application of multifunctional nanomaterials in Alzheimer’s disease: A potential theranostics strategy

Xu, Y., Zhao, M.-N., Zhou, D., Zheng, T., & Zhang, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111360 · Cited by 37 · see citing works

Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms

Cheng, G., Xie, A., Yan, Z., Zhu, X., Song, Y., & Chen, T. (2023) · Brain‐X · doi:10.1002/brx2.27 · Cited by 34 · see citing works